Publication | Closed Access

Postmortem molecular screening for mutations in ryanodine receptor type 1 (RYR1) gene in psychiatric patients suspected of having died of neuroleptic malignant syndrome

PsychiatryPostmortem Molecular ScreeningNeuroleptic Malignant SyndromePsychiatric GeneticsPsychiatric PatientsSchizophreniaNeuropsychiatryNeurologyBiological PsychiatryNeuropathologyMedicineNeurogenetics